This is a common, harmless skin condition that mostly affects babies and young children. It causes small, raised bumps that look yellowish-red. These bumps are usually found on the skin, sometimes in the eyes or other parts of the body. It's not serious and usually goes away on its own without needing treatment.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Juvenile xanthogranuloma (JXG) is a benign growth that most often appears as a small, firm, smooth bump on the skin of a baby or young child. The bump is usually 1 to 10 millimeters across and often starts out red, then turns yellow or orange-brown as it matures. It commonly appears on the head or neck, though the trunk, arms and legs can be affected too. Most children have a single bump that causes no pain or itching, and it usually fades on its own over a few years. JXG is made up of histiocytes, a type of immune cell that normally helps clear debris from tissues. In JXG these cells gather in one spot and fill with fat, which gives the bump its yellow color. Doctors classify it as a non-Langerhans cell histiocytosis, the most common member of that group. That distinguishes it from Langerhans cell histiocytosis, a different condition that more often needs treatment. JXG is not cancer and is not related to cholesterol levels in the blood. About 85% of cases appear before age 1, and some babies are born with a lesion. Less often, JXG appears for the first time in adults. Uncommonly, a child has many bumps, and in rare cases JXG develops in the eye or in internal organs, which is why a new diagnosis comes with a check for those possibilities.
The cause of JXG is unknown. Researchers have suggested it may be an unusual reaction of the immune system to a minor injury or infection, or that it involves changes in the cells themselves, but none of these explanations has been confirmed. Nothing a parent did or did not do causes it, and it is not contagious. JXG is more common in boys in childhood. It is also more common in children with neurofibromatosis type 1 (NF1), an inherited condition that causes flat light-brown skin patches called cafe-au-lait spots and benign nerve growths. Up to 1 in 10 people with NF1 may develop JXG. An older analysis suggested that children who have both NF1 and JXG have a higher risk of juvenile myelomonocytic leukemia (JMML), a rare childhood blood cancer, but later studies have questioned that link. If a child with JXG also has several cafe-au-lait spots, it is worth asking whether NF1 should be considered.
A dermatologist or pediatrician can often recognize JXG from its look, especially its yellow-orange color. A dermatoscope, a handheld magnifying light, can show a pattern typical of JXG. When the appearance is not clear-cut, a skin biopsy (removing a small sample, or the whole bump, for examination under a microscope) confirms it. Under the microscope JXG shows fat-filled histiocytes and characteristic cells called Touton giant cells, which helps tell it apart from look-alikes such as mastocytoma, molluscum contagiosum or Langerhans cell histiocytosis. The doctor will also check the rest of the skin and ask about the eyes. Specialists differ on whether every child needs an eye exam. Many recommend one from an eye doctor (ophthalmologist), particularly for children age 2 or younger, those with several skin lesions, or those newly diagnosed, because these children have the highest chance of eye involvement. Some studies have found eye involvement so rare that a routine exam may not be needed for a child with no eye symptoms. Any eye symptom calls for an exam. A single typical bump usually needs no further tests. When a child has many bumps or other symptoms, the doctor may order blood counts, liver and kidney blood tests, or imaging such as an abdominal ultrasound or a brain scan to look for internal involvement.
Most skin JXG needs no treatment. Because the bumps usually shrink and fade on their own, the usual approach for a typical single lesion is to watch it over time. Removing it by minor surgery is an option when a lesion is in an awkward spot that interferes with function, is ulcerated or uncomfortable, is causing distress because of its appearance, or needs to be removed to confirm the diagnosis. Surgery leaves a scar, and in one large series about 1 in 10 removed lesions came back at the same spot, so removal is a trade-off rather than an automatic choice. JXG in the eye is treated differently, because waiting can put vision at risk. Corticosteroid eye drops, given at a high dose and tapered slowly over several months, are the main treatment for JXG of the iris (the colored part of the eye). If drops are not enough, an eye doctor may inject steroid near the eye or use steroid medicine by mouth, and low-dose radiation has been used in stubborn cases. Eye pressure is monitored and treated if glaucoma develops. JXG on the eyelid is often simply removed. For the rare child with JXG in internal organs, care is led by a pediatric hematology-oncology team. Some of these children are observed because the disease can settle on its own, while those whose organs are not working properly may receive chemotherapy. There is no single standard treatment for this form, so plans are individualized.
For most children, JXG is a temporary skin finding. New bumps may still appear for a while after diagnosis, but lesions typically stop growing and then fade over about one to six years. As they fade they often become flatter and wrinkled and may leave a slightly lighter or thin patch of skin. Larger lesions, especially ones present at birth, can break down into an open sore and heal with a scar. Children with skin-only JXG generally feel well, and the condition does not limit their activities. Follow-up is usually simple: periodic checks with the pediatrician or dermatologist to confirm lesions are behaving as expected, plus any eye visits the care team recommends. Lesions that begin in adulthood tend to last longer than those in children. The outlook is less predictable when JXG involves the eye or internal organs. Iris JXG can cause bleeding inside the eye, raised eye pressure (glaucoma) and permanent vision loss if it is not treated promptly, which is why eye symptoms are taken seriously. Internal involvement, most often of the brain, liver or lungs, is rare. Many of these children recover fully, some have lasting effects, and in rare cases the disease has been fatal. Children with NF1 and JXG are followed by their NF1 care team, which may include watching blood counts.
Arrange a visit with a pediatrician or dermatologist for any new yellow, orange or red-brown bump on a baby or child, so it can be identified and checked for features that need further evaluation. Return sooner if a lesion grows quickly, bleeds, breaks open or behaves differently from what the doctor described, or if many new bumps appear. Contact the care team the same day for an eye exam if a child with JXG, or a baby with suspected JXG, has a red eye, blood visible in the front of the eye, or a change in the color of one iris so the eyes no longer match. These can be signs of JXG inside the eye, where prompt treatment helps protect vision. For a child with many lesions or known internal involvement, tell the care team about any new, unexplained symptoms that last more than a few days, since symptoms are what guide whether further tests are needed.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Juvenile Xanthogranuloma is like, what's helped you, or ask the community a question.